A carregar...

Safety of intravenous immunoglobulin treatment.

In a prospective clinical and biochemical study of 16 patients treated with high doses of an immunoglobulin product that had been modified for intravenous use by mild pepsin treatment at pH 4 no evidence of hepatitis could be found. This contrasts with recent reports that intravenous immunoglobulin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Atrah, H I, Crawford, R J, Dow, B C, Mitchell, R
Formato: Artigo
Idioma:Inglês
Publicado em: 1985
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC499468/
https://ncbi.nlm.nih.gov/pubmed/3932489
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!